# A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

> **NCT00631462** · PHASE1 · COMPLETED · sponsor: **TargeGen** · enrollment: 59 (actual)

## Conditions studied

- Myelofibrosis

## Interventions

- **DRUG:** TG101348

## Key facts

- **NCT ID:** NCT00631462
- **Lead sponsor:** TargeGen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2009-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631462, "A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00631462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*